Is Taysha Gene Therapies, Inc. (TSHA) a Buy, Sell, or Hold?
NASDAQ : TSHA
Taysha Gene Therapies, Inc. — Competitors
$5.52 USD
-$0.31 (-5.32%)
- Volume
- 1.81M
- Average Volume
- 3.02M
- Market Capitalization
- $1.79B
- P/E Ratio
- -14.42
- Dividend Yield
- 0.00%
- Price Target
- $14.00
- Year High
- $7.30
- Year Low
- $2.54
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $14.04
TSHA vs. The Competition
| Properties | TSHA | ANAB | ATAI | BBOT |
|---|---|---|---|---|
| Market Cap | $1.79B | $2.34B | $2.66B | $706.54M |
| Shares Outstanding | $324.86M | $43.12M | $369.95M | $80.11M |
| P/E Ratio | -14.42 | -63.71 | -2.39 | -1.54 |
| EPS | -0.35 | -0.93 | -2.93 | -4.95 |
| Day Low | 5.46 | 53.26 | 7.1607 | 8.45 |
| Day High | 5.95 | 54.4099 | 7.19 | 8.93 |
| Year Low | 2.54 | 11.404 | 3.06 | 7 |
| Year High | 7.3 | 72.36 | 7.22 | 14.87 |
| Average Price 50 | 5.9812 | 58.5278 | 4.871 | 8.2226 |
| Average Price 200 | 5.2349 | 41.43878 | 4.36858 | 10.2191 |
| Volume | 1.81M | 486.85K | 6.96M | 186.15K |
| Average Volume | - | - | - | - |